Clinical trial
Levocetirizine 5 mg: Reduction of Symptoms, Airway Resistance and Sleep…
NCT00355771 · Institut für Atemwegsforschung GmbH, Industry · Completed
Key facts
| NCT number | NCT00355771 |
|---|---|
| Title | Levocetirizine 5 mg: Reduction of Symptoms, Airway Resistance and Sleep Impairment in Persistent Allergic Rhinitis |
| Official title | Placebo Controlled Pilot Study on the Efficacy of Levocetirizine 5 mg in Reducing Symptoms, Airway Resistance, and Sleep Impairment in Patients With Persistent Allergic Rhinitis |
| Lead sponsor | Institut für Atemwegsforschung GmbH, Industry |
| Collaborators | UCB Pharma Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Allergic Rhinitis |
| Intervention type | Drug |
| Interventions | Levocetirizine, Placebo |
| Enrollment | 100 |
| Start date | Jun 1, 2006 |
| Primary completion | Nov 1, 2007 |
| Completion | Nov 1, 2007 |
| First posted | Jul 25, 2006 |
| Last update posted | Jan 15, 2008 |
| Countries | China |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: